Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Adam Cohen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Phenomena

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Zoethout Remco W M; Schoemaker Rik C; Zuurman Lineke; van Pelt Hans; Dahan Albert; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.
van Haarst Aernout D; Dijkmans Anneke C; Weimann Hans-Josef; Kemme Michiel J B; Bosch Jacobus J; Schoemaker Rik C; Cohen Adam F; Burggraaf Jacobus
Clinically important interaction between tedisamil and verapamil.
Franson Kari L; Dubois Eline A; de Kam Marieke L; Burggraaf Jacobus; Cohen Adam F
Creating a culture of thoughtful prescribing.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Adam Cohen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zoethout Remco W M; Schoemaker Rik C; Zuurman Lineke; van Pelt Hans; Dahan Albert; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers.
British journal of clinical pharmacology 2009;68(4):524-34.
2009: van Haarst Aernout D; Dijkmans Anneke C; Weimann Hans-Josef; Kemme Michiel J B; Bosch Jacobus J; Schoemaker Rik C; Cohen Adam F; Burggraaf Jacobus
Clinically important interaction between tedisamil and verapamil.
Journal of clinical pharmacology 2009;49(5):560-7.
2009: Franson Kari L; Dubois Eline A; de Kam Marieke L; Burggraaf Jacobus; Cohen Adam F
Creating a culture of thoughtful prescribing.
Medical teacher 2009;31(5):415-9.
2008: Zoethout Remco W M; van Gerven Joop M A; Dumont Glenn J H; Paltansing Sunita; van Burgel Nathalie D; van der Linden Monique; Dahan Albert; Cohen Adam F; Schoemaker Rik C
A comparative study of two methods for attaining constant alcohol levels.
British journal of clinical pharmacology 2008;66(5):674-81.
2008: Cohen Adam F
Methods in clinical pharmacology--a tale of two worlds.
British journal of clinical pharmacology 2008;66(5):585-7.
2008: Liem-Moolenaar M; Cerneus D; Molloy C J; End D; Brown K H; de Kam M L; Cohen A F; van Hensbergen Y; Burggraaf J
Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.
Clinical pharmacology and therapeutics 2008;84(4):481-7.
2008: Franson Kari L; Dubois Eline A; de Kam Marieke L; Cohen Adam F
Measuring learning from the TRC pharmacology E-Learning program.
British journal of clinical pharmacology 2008;66(1):135-41.
2008: van Bronswijk H; Dubois E A; Pijl H; Cohen A F
[New drugs; exenatide and sitagliptin]
Nederlands tijdschrift voor geneeskunde 2008;152(15):876-9.
2008: van Bronswijk H; Dubois E A; van Gerven J M A; Cohen A F
[New drugs; natalizumab]
Nederlands tijdschrift voor geneeskunde 2008;152(9):499-500.
2008: van Bronswijk H; Dubois E A; van Meurs J C; Cohen A F
[New drugs; pegaptanib and ranibizumab]
Nederlands tijdschrift voor geneeskunde 2008;152(2):82-4.
2008: de Haas S L; de Visser S J; van der Post J P; Schoemaker R C; van Dyck K; Murphy M G; de Smet M; Vessey L K; Ramakrishnan R; Xue L; Cohen A F; van Gerven J M A
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
Journal of psychopharmacology (Oxford, England) 2008;22(1):24-32.
2008: Broeyer F J F; van Aken B E; Suzuki J; Kemme M J B; Schoemaker H C; Cohen A F; Mizushima Y; Burggraaf J
The pharmacokinetics and effects of a long-acting preparation of superoxide dismutase (PC-SOD) in man.
British journal of clinical pharmacology 2008;65(1):22-9.
2007: Franson Kari L; Dubois Eline A; van Gerven Joop M A; Cohen Adam F
Development of visual pharmacology education across an integrated medical school curriculum.
Journal of visual communication in medicine 2007;30(4):156-61.
2007: van Bronswijk H; Dubois E A; Osanto S; Cohen A F
[New drugs; sunitinib and sorafenib]
Nederlands tijdschrift voor geneeskunde 2007;151(52):2888-90.
2007: van Bronswijk H; Dubois E A; van Dissel J T; Cohen A F
[New drugs; daptomycin]
Nederlands tijdschrift voor geneeskunde 2007;151(50):2777-8.
2007: van der Vorst Maria M J; Kist-van Holthe Joana E; den Hartigh Jan; van der Heijden Albert J; Cohen Adam F; Burggraaf Jacobus
Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery.
British journal of clinical pharmacology 2007;64(6):796-803.
2007: Boots Isabelle; Sukhai Rám N; Klein Richard H; Holl Robert A; Wit Jan M; Cohen Adam F; Burggraaf Jacobus
Stimulation programs for pediatric drug research--do children really benefit?
European journal of pediatrics 2007;166(8):849-55.
2007: de Haas S L; de Visser S J; van der Post J P; de Smet M; Schoemaker R C; Rijnbeek B; Cohen A F; Vega J M; Agrawal N G B; Goel T V; Simpson R C; Pearson L K; Li S; Hesney M; Murphy M G; van Gerven J M A
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2007;21(4):374-83.
2007: Boot J D; de Kam M L; Mascelli M A; Miller B; van Wijk R Gerth; de Groot H; Cohen A F; Diamant Z
Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
Allergy 2007;62(4):378-84.
2007: Boot Johan D; de Haas Sanne; Tarasevych Svetlana; Roy Christine; Wang Lin; Amin Dilip; Cohen Judith; Sterk Peter J; Miller Barry; Paccaly Anne; Burggraaf Jacobus; Cohen Adam F; Diamant Zuzana
Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
American journal of respiratory and critical care medicine 2007;175(5):450-7.
2006: van Doorn Martijn B A; Espirito Santo Sonia M; Meijer Piet; Kamerling Ingrid M; Schoemaker Rik C; Dirsch Verena; Vollmar Angelika; Haffner Thomas; Gebhardt Rolf; Cohen Adam F; Princen Hans M; Burggraaf Jacobus
Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects.
The American journal of clinical nutrition 2006;84(6):1324-9.
2006: Rad M; Hümpel M; Schaefer O; Schoemaker R C; Schleuning W-D; Cohen A F; Burggraaf J
Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women.
British journal of clinical pharmacology 2006;62(3):288-96.
2006: Twiss I M; van den Berk A H M; de Kam M L; Bosch J J; Cohen A F; Vermeij P; Burggraaf J
A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.
Journal of clinical pharmacology 2006;46(4):483-7.
2005: Boot J D; Tarasevych S; Sterk P J; Schoemaker R C; Wang L; Amin D; Cohen A F; Diamant Z
Reversal of the late asthmatic response increases exhaled nitric oxide.
Respiratory medicine 2005;99(12):1591-4.
2005: van Doorn Martijn B A; Burggraaf Jacobus; van Dam Tijtje; Eerenberg Anke; Levi Marcel; Hack Cornelis E; Schoemaker Rik C; Cohen Adam F; Nuijens Jan
A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema.
The Journal of allergy and clinical immunology 2005;116(4):876-83.
2005: van der Post J P; de Visser S J; de Kam M L; Woelfler M; Hilt D C; Vornov J; Burak E S; Bortey E; Slusher B S; Limsakun T; Cohen A F; van Gerven J M A
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.
British journal of clinical pharmacology 2005;60(2):128-36.
2005: Dumont G J H; de Visser S J; Cohen A F; van Gerven J M A;
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.
British journal of clinical pharmacology 2005;59(5):495-510.
2005: Cohen Judith; Burggraaf Jacobus; Schoemaker Rik C; Sterk Peter J; Cohen Adam F; Diamant Zuzana
Relationship between airway responsiveness to neurokinin A and methacholine in asthma.
Pulmonary pharmacology & therapeutics 2005;18(3):171-6.
2004: Buijs M M; Romijn J A; Burggraaf J; de Kam M L; Frölich M; Ackermans M T; Sauerwein H P; Cohen A F; Meinders A E; Pijl H
Glucose homeostasis in abdominal obesity: hepatic hyperresponsiveness to growth hormone action.
American journal of physiology. Endocrinology and metabolism 2004;287(1):E63-8.
2004: van der Post J P; de Visser S J; Schoemaker R C; Cohen A F; van Gerven J M A
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.
Journal of psychopharmacology (Oxford, England) 2004;18(2):221-7.
2004: Kamerling I M C; Van Haarst A D; De Kam M L; Cohen A F; Masclee A A M; Burggraaf J
Gallbladder volume as a biomarker for the motilin effect in healthy volunteers and patients with functional dyspepsia.
Alimentary pharmacology & therapeutics 2004;19(7):797-804.
2004: Kamerling Ingrid M C; van Haarst Aernout D; Burggraaf Jacobus; Schoemaker Rik C; de Kam Marieke L; Heinzerling Hartmut; Cohen Adam F; Masclee Ad A M
Effects of a nonpeptide motilin receptor antagonist on proximal gastric motor function.
British journal of clinical pharmacology 2004;57(4):393-401.
2004: van der Post J; de Waal P P; de Kam M L; Cohen A F; van Gerven J M A
No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity.
Journal of psychopharmacology (Oxford, England) 2004;18(1):109-14.
2004: Gijsman H J; Cohen A F; van Gerven J M A
The application of the principles of clinical drug development to pharmacological challenge tests of the serotonergic system.
Journal of psychopharmacology (Oxford, England) 2004;18(1):7-13.
2003: Pieters M S M; van Steveninck A F; Schoemaker R C; Kroon J M; van Gerven J M A; Cohen A F
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2003;17(3):269-72.
2003: Rijnbeek B; de Visser S J; Franson K L; Cohen A F; van Gerven J M A
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2003;17(2):196-203.
2003: Kamerling I M C; Burggraaf J; van Haarst A D; Oppenhuizen-Duinker M F; Schoemaker H C; Biemond I; Jones R; Heinzerling H; Cohen A F; Masclee A A M
The effect of motilin on the rectum in healthy volunteers.
British journal of clinical pharmacology 2003;55(6):538-43.
2003: Kemme Michiel J B; vd Post Jeroen P; Schoemaker Rik C; Straub Matthias; Cohen Adam F; van Gerven Joop M A
Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension.
British journal of clinical pharmacology 2003;55(6):518-25.
2003: Kamerling Ingrid M C; Van Haarst Aernout D; Burggraaf Jacobus; Schoemaker Rik C; Biemond Izak; Heinzerling Hartmut; Jones Richard; Cohen Adam F; Masclee Ad A M
Motilin effects on the proximal stomach in patients with functional dyspepsia and healthy volunteers.
American journal of physiology. Gastrointestinal and liver physiology 2003;284(5):G776-81.
2003: Kemme Michiel J B; Burggraaf Jacobus; Schoemaker Rik C; Cohen Adam F; Kluft Cornelis; Chia Stanley; Webb David J; Newby David E
Local tissue factor pathway inhibitor release in the human forearm.
Thrombosis and haemostasis 2003;89(3):438-45.
2003: Buijs Madelon M; Burggraaf Jacobus; Wijbrandts Carla; de Kam Marieke L; Frölich Marijke; Cohen Adam F; Romijn Johannes A; Sauerwein Hans P; Meinders A Edo; Pijl Hanno
Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism.
The American journal of clinical nutrition 2003;77(3):544-50.
2003: Kemme Michiel J; Schoemaker Rik C; Burggraaf Jacobus; van der Linden Monique; Noordzij Marina; Moerland Matthijs; Kluft Cornelis; Cohen Adam F
Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.
Journal of pharmacokinetics and pharmacodynamics 2003;30(1):3-22.
2003: de Visser S J; van der Post J P; de Waal P P; Cornet F; Cohen A F; van Gerven J M A
Biomarkers for the effects of benzodiazepines in healthy volunteers.
British journal of clinical pharmacology 2003;55(1):39-50.
2002: van der Post J; Noordzij L A W; de Kam M L; Blauw G J; Cohen A F; van Gerven J M A
Evaluation of tests of central nervous system performance after hypoxemia for a model for cognitive impairment.
Journal of psychopharmacology (Oxford, England) 2002;16(4):337-43.
2002: Kemme Michiel J B; Burggraaf Jacobus; Schoemaker Rik C; Kluft Cornelis; Cohen Adam F
Quantification of heparin-induced TFPI release: a maximum release at low heparin dose.
British journal of clinical pharmacology 2002;54(6):627-34.
2002: Buijs Madelon M; Romijn Johannes A; Burggraaf Jacobus; De Kam Marieke L; Cohen Adam F; Frölich Marijke; Stellaard Frans; Meinders A Edo; Pijl Hanno
Growth hormone blunts protein oxidation and promotes protein turnover to a similar extent in abdominally obese and normal-weight women.
The Journal of clinical endocrinology and metabolism 2002;87(12):5668-74.
2002: de Visser Saco J; van der Post Jeroen-Paul; Nanhekhan Loyd; Schoemaker Rik C; Cohen Adam F; van Gerven Joop M A
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patients.
Clinical pharmacology and therapeutics 2002;72(4):419-28.
2002: Schoemaker Rik C; van dDer Vorst Maria M j; van Heel Isabelle Ruijs-Dudok; Cohen Adam F; Burggraaf Jacobus;
Development of an optimal furosemide infusion strategy in infants with modeling and simulation.
Clinical pharmacology and therapeutics 2002;72(4):383-90.
2002: Faaij R A; Burggraaf J; Schoemaker R C; Van Amsterdam R G M; Cohen A F
Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.
British journal of clinical pharmacology 2002;54(3):304-8.
2002: Kamerling I M C; van Haarst A D; Burggraaf J; de Kam M; Biemond I; Jones R; Cohen A F; Masclee A A M
Exogenous motilin affects postprandial proximal gastric motor function and visceral sensation.
Digestive diseases and sciences 2002;47(8):1732-6.
2002: Buijs Madelon M; Burggraaf Jacobus; Langendonk Janneke G; Schoemaker Rik C; Frölich Marijke; Arndt Jan-Willem; Cohen Adam F; Romijn Johannes A; Ackermans Mariette T; Sauerwein Hans P; Meinders A Edo; Pijl Hanno
Hyposomatotropism blunts lipolysis in abdominally obese women.
The Journal of clinical endocrinology and metabolism 2002;87(8):3851-8.
2002: van der Post J; Schram M T; Schoemaker R C; Pieters M S M; Fuseau E; Pereira A; Baggen S; Cohen A F; van Gerven J M A
CNS effects of sumatriptan and rizatriptan in healthy female volunteers.
Cephalalgia : an international journal of headache 2002;22(4):271-81.
2002: Schoemaker Rik C; Buijs Madelon M; Pijl Hanno; Burggraaf Jacobus; Cohen Adam F
Modeling the influence of growth hormone on lipolysis.
Journal of pharmacokinetics and pharmacodynamics 2002;29(2):157-70.
2002: Gijsman Harm J; van Gerven Joop M A; de Kam Marieke L; Schoemaker Rik C; Pieters Monique S M; Weemaes Margo; de Rijk Roel; van der Post Jeroen; Cohen Adam F
Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers.
Journal of clinical psychopharmacology 2002;22(2):183-9.
2002: Gijsman Harm J; van Gerven Joop M A; Verkes Robbert Jan; Schoemaker Rik C; Pieters Monique S M; Pennings Ed J M; Hessing Trees J; Cohen Adam F
Saccadic peak velocity and EEG as end-points for a serotonergic challenge test.
Human psychopharmacology 2002;17(2):83-9.
2002: Kamerling I M C; Van Haarst A D; Burggraaf J; Schoemaker H C; Biemond I; Jones R; Cohen A F; Masclee A A M
Dose-related effects of motilin on proximal gastrointestinal motility.
Alimentary pharmacology & therapeutics 2002;16(1):129-35.
2002: Ollier Céline; Faaij Richard A; Santoni Alix; Duvauchelle Thierry; van Haard Paul M M; Schoemaker Rik C; Cohen Adam F; de Greef Rik; Burggraaf Jacobus
Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
Clinical pharmacokinetics 2002;41 Suppl 2():31-7.
2002: Faaij Richard A; Burggraaf Jacobus; Schoemaker Rik C; de Greef Rik; Cohen Adam F
The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin.
Clinical pharmacokinetics 2002;41 Suppl 2():27-9.
2001: Pijl H; de Meijer P H; Langius J; Coenegracht C I; van den Berk A H; Chandie Shaw P K; Boom H; Schoemaker R C; Cohen A F; Burggraaf J; Meinders A E
Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.
The Journal of clinical endocrinology and metabolism 2001;86(12):5848-53.
2001: Pijl H; Langendonk J G; Burggraaf J; Frölich M; Cohen A F; Veldhuis J D; Meinders A E
Altered neuroregulation of GH secretion in viscerally obese premenopausal women.
The Journal of clinical endocrinology and metabolism 2001;86(11):5509-15.
2001: Kemme M J; Faaij R A; Schoemaker R C; Kluft C; Meijer P; Cohen A F; Burggraaf J
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulants.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(7):583-91.
2001: Kemme M J; Burggraaf J; Schoemaker R C; Cohen A F
No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteers.
Thrombosis research 2001;103(1):9-16.
2001: Burggraaf J; Westendorp R G; in't Veen J C; Schoemaker R C; Sterk P J; Cohen A F; Blauw G J
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients.
Thorax 2001;56(7):567-9.
2001: Burggraaf J; Tulen J H; Lalezari S; Schoemaker R C; De Meyer P H; Meinders A E; Cohen A F; Pijl H
Sympathovagal imbalance in hyperthyroidism.
American journal of physiology. Endocrinology and metabolism 2001;281(1):E190-5.
2001: Twiss I M; Burggraaf J; Schoemaker R C; van Elburg R M; den Hartigh J; Cohen A F; Vermeij P
The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.
Clinical pharmacology and therapeutics 2001;69(6):431-7.
2001: de Visser S J; van Gerven J M; Schoemaker R C; Cohen A F
Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
British journal of clinical pharmacology 2001;51(5):423-8.
2001: van der Vorst M M; Ruys-Dudok van Heel I; Kist-van Holthe J E; den Hartigh J; Schoemaker R C; Cohen A F; Burggraaf J
Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery.
Intensive care medicine 2001;27(4):711-5.
2001: Faaij R A; van Griensven J M; Schoemaker R C; Goggin T; Guenzi A; Kroon J M; Burggraaf J; Cohen A F
The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers.
European journal of clinical pharmacology 2001;57(1):25-9.
2001: Burggraaf J; Lalezari S; Emeis J J; Vischer U M; de Meyer P H; Pijl H; Cohen A F
Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol.
Thyroid : official journal of the American Thyroid Association 2001;11(2):153-60.
2001: de Visser S J; van der Post J; Pieters M S; Cohen A F; van Gerven J M
Biomarkers for the effects of antipsychotic drugs in healthy volunteers.
British journal of clinical pharmacology 2001;51(2):119-32.
2001: Verkes R J; Gijsman H J; Pieters M S; Schoemaker R C; de Visser S; Kuijpers M; Pennings E J; de Bruin D; Van de Wijngaart G; Van Gerven J M; Cohen A F
Cognitive performance and serotonergic function in users of ecstasy.
Psychopharmacology 2001;153(2):196-202.
2001: Langendonk J G; Veldhuis J D; Burggraaf J; Schoemaker R C; Cohen A F; Meinders A E; Pijl H
Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(1):R225-32.
2000: Burggraaf J; Kemme M J; Muller L M; Schoemaker R C; Cohen A F
The influence of the hand circulation on the assessment of venous distensibility of the human forearm with venous occlusion plethysmography.
British journal of clinical pharmacology 2000;50(6):621-3.
2000: Kemme M J; Burggraaf J; Schoemaker R C; Cohen A F; Blauw G J
No evidence for functional involvement of 5-HT2B receptors in serotonin-induced vasodilatation in the human forearm.
Journal of cardiovascular pharmacology 2000;36(6):699-703.
2000: Burggraaf J; Schoemaker R C; Lentjes E G; Cohen A F
Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2000;12(2):133-9.
2000: de Roode A; van Gerven J M; Schoemaker R C; Engbers F H; Olieman W; Kroon J R; Cohen A F; Bovill J G
A comparison of the effects of propofol and midazolam on memory during two levels of sedation by using target-controlled infusion.
Anesthesia and analgesia 2000;91(5):1056-61.
2000: Karlsson M O; Schoemaker R C; Kemp B; Cohen A F; van Gerven J M; Tuk B; Peck C C; Danhof M
A pharmacodynamic Markov mixed-effects model for the effect of temazepam on sleep.
Clinical pharmacology and therapeutics 2000;68(2):175-88.
2000: Kemme M J; Burggraaf J; Schoemaker R C; Paulson S; Karim A; Lentjes E G; Childs A; Braeckman R A; Cohen A F
The influence of reduced liver blood flow on the pharmacokinetics and pharmacodynamics of recombinant tissue factor pathway inhibitor.
Clinical pharmacology and therapeutics 2000;67(5):504-11.
1999: Faaij R A; Van Gerven J M; Jolivet-Landreau I; Masclee A A; Vendrig E M; Schoemaker R C; Jacobs L D; Cohen A F
Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn.
Alimentary pharmacology & therapeutics 1999;13(12):1605-10.
1999: Langendonk J G; Meinders A E; Burggraaf J; Frölich M; Roelen C A; Schoemaker R C; Cohen A F; Pijl H
Influence of obesity and body fat distribution on growth hormone kinetics in humans.
The American journal of physiology 1999;277(5 Pt 1):E824-9.
1999: Gijsman H J; Verkes R J; van Gerven J M; Cohen A F
MDMA study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(4):597.
1999: Van Haarst A D; Van Gerven J M; Cohen A F; De Smet M; Sterrett A; Birk K L; Fisher A L; De Puy M E; Goldberg M R; Musson D G
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
British journal of clinical pharmacology 1999;48(2):190-6.
1999: Cath D C; Gijsman H J; Schoemaker R C; van Griensven J M; Troost N; van Kempen G M; Cohen A F
The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome.
Psychopharmacology 1999;144(2):137-43.
1999: Faaij R A; Srivastava N; van Griensven J M; Schoemaker R C; Kluft C; Burggraaf J; Cohen A F
The oral bioavailability of pentosan polysulphate sodium in healthy volunteers.
European journal of clinical pharmacology 1999;54(12):929-35.
1999: van Steveninck A L; van Berckel B N; Schoemaker R C; Breimer D D; van Gerven J M; Cohen A F
The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.
Journal of psychopharmacology (Oxford, England) 1999;13(1):10-7.
1998: van Gerven J M; Uchida E; Uchida N; Pieters M S; Meinders A J; Schoemaker R C; Nanhekhan L V; Kroon J M; de Visser S J; Altorf B; Yasuda K; Yasuhara H; Cohen A F
Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers.
Journal of clinical pharmacology 1998;38(12):1129-36.
1998: van Haarst A D; van 't Klooster G A; van Gerven J M; Schoemaker R C; van Oene J C; Burggraaf J; Coene M C; Cohen A F
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.
Clinical pharmacology and therapeutics 1998;64(5):542-6.
1998: Schoemaker R C; van Gerven J M; Cohen A F
Estimating potency for the Emax-model without attaining maximal effects.
Journal of pharmacokinetics and biopharmaceutics 1998;26(5):581-93.
1998: Boeijinga J K; van Meegen E; van den Ende R; Schook C E; Cohen A F
Lack of interaction between tramadol and coumarins.
Journal of clinical pharmacology 1998;38(10):966-70.
1998: Burggraaf J; van Haarst A D; Fockens P; Schoemaker H C; Krauwinkel W J; Cohen A F
The gastrointestinal passage and release of beclomethasone dipropionate from oral delivery systems in ileostomy volunteers.
British journal of clinical pharmacology 1998;46(3):207-14.
1998: Gijsman H J; Van Gerven J M; Tieleman M C; Schoemaker R C; Pieters M S; Ferrari M D; Cohen A F; Van Kempen G M
Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers.
Journal of clinical psychopharmacology 1998;18(4):289-95.
1998: Schoemaker R C; Burggraaf J; Cohen A F
Assessment of hepatic blood flow using continuous infusion of high clearance drugs.
British journal of clinical pharmacology 1998;45(5):463-9.
1998: Burggraaf J; Schoemaker R C; Kroon J M; Cohen A F
The influence of nifedipine and captopril on liver blood flow in healthy subjects.
British journal of clinical pharmacology 1998;45(5):447-51.
1998: Langendonk J G; Pijl H; Toornvliet A C; Burggraaf J; Frölich M; Schoemaker R C; Doornbos J; Cohen A F; Meinders A E
Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss.
The Journal of clinical endocrinology and metabolism 1998;83(5):1706-12.
1998: Burggraaf J; Schoemaker R C; Terpstra I J; Cohen A F
A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteers.
Journal of clinical pharmacology 1998;38(1):45-53.
1998: van Griensven J M; Koster R W; Burggraaf J; Huisman L G; Kluft C; Kroon R; Schoemaker R C; Cohen A F
Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
Clinical pharmacology and therapeutics 1998;63(1):39-47.
1997: Boeijinga J K; van Meegen E; van den Ende R; Schook C E; Cohen A F
Is there interaction between tramadol and phenprocoumon?
Lancet 1997;350(9090):1552-3.
1997: van Gerven J M; Roncari G; Schoemaker R C; Massarella J; Keesmaat P; Kooyman H; Heizmann P; Zell M; Cohen A F; Dingemanse J
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
British journal of clinical pharmacology 1997;44(5):487-93.
1997: Dingemanse J; van Gerven J M; Schoemaker R C; Roncari G; Oberyé J J; van Oostenbruggen M F; Massarella J; Segala P; Zell M; Cohen A F
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
British journal of clinical pharmacology 1997;44(5):477-86.
1997: Tuk B; Oberyé J J; Pieters M S; Schoemaker R C; Kemp B; van Gerven J; Danhof M; Kamphuisen H A; Cohen A F; Breimer D D; Peck C C
Pharmacodynamics of temazepam in primary insomnia: assessment of the value of quantitative electroencephalography and saccadic eye movements in predicting improvement of sleep.
Clinical pharmacology and therapeutics 1997;62(4):444-52.
1997: van Griensven J M; Koster R W; Hopkins G R; Beier H; Günzler W A; Kroon R; Schoemaker R C; Cohen A F
Effect of changes in liver blood flow on the pharmacokinetics of saruplase in patients with acute myocardial infarction.
Thrombosis and haemostasis 1997;78(3):1015-20.
1997: van Steveninck A L; Wallnöfer A E; Schoemaker R C; Pieters M S; Danhof M; van Gerven J M; Cohen A F
A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population.
British journal of clinical pharmacology 1997;44(3):267-75.
1996: van Griensven J M; Huisman L G; Stuurman T; Dooijewaard G; Kroon R; Schoemaker R C; Kluft K; Cohen A F
Effects of increased liver blood flow on the kinetics and dynamics of recombinant tissue-type plasminogen activator.
Clinical pharmacology and therapeutics 1996;60(5):504-11.
1996: Burggraaf J; Schoemaker H C; Cohen A F
Assessment of changes in liver blood flow after food intake--comparison of ICG clearance and echo-Doppler.
British journal of clinical pharmacology 1996;42(4):499-502.
1996: van Gerven J M; Schoemaker R C; Jacobs L D; Reints A; Ouwersloot-van der Meij M J; Hoedemaker H G; Cohen A F
Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary.
British journal of clinical pharmacology 1996;42(4):475-81.
1996: Visser W H; Burggraaf J; Muller L M; Schoemaker R C; Fowler P A; Cohen A F; Ferrari M D
Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response.
Clinical pharmacology and therapeutics 1996;60(4):452-60.
1996: Schoemaker R C; Cohen A F
Estimating impossible curves using NONMEM.
British journal of clinical pharmacology 1996;42(3):283-90.
1996: van Steveninck A L; Gieschke R; Schoemaker R C; Roncari G; Tuk B; Pieters M S; Breimer D D; Cohen A F
Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol.
British journal of clinical pharmacology 1996;41(6):565-73.
1996: Kars M E; Pijl H; Cohen A F; Frölich M; Schoemaker H C; Brandenburg H C; Meinders A E
Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women.
Clinical endocrinology 1996;44(5):541-6.
1995: van Griensven J M; Jusko W J; Lemkes H H; Kroon R; Verhorst C J; Chiang S T; Cohen A F
Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes.
Clinical pharmacology and therapeutics 1995;58(6):631-40.
1995: Pijl H; Cohen A F; Verkes R J; Koppeschaar H P; Iestra J A; Schoemaker H C; Frölich M; Onkenhout W; Meinders A E
Plasma amino acid ratios related to brain serotonin synthesis in response to food intake in bulimia nervosa.
Biological psychiatry 1995;38(10):659-68.
1995: van Griensven J M; Burggraaf K J; Gerloff J; Günzler W A; Beier H; Kroon R; Huisman L G; Schoemaker R C; Kluft K; Cohen A F
Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase.
Clinical pharmacology and therapeutics 1995;57(4):381-9.
1995: Aldenkamp A P; Baker G; Pieters M S; Schoemaker H C; Cohen A F; Schwabe S
The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity.
Epilepsy research 1995;20(3):229-39.
1995: van Griensven J M; Schoemaker R C; Cohen A F; Luus H G; Seibert-Grafe M; Röthig H J
Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril.
European journal of clinical pharmacology 1995;47(6):513-8.
1994: Koster R W; Cohen A F; Hopkins G R; Beier H; Günzler W A; van der Wouw P A
Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction.
Thrombosis and haemostasis 1994;72(5):740-4.
1994: van Steveninck A L; Schoemaker H C; den Hartigh J; Pieters M S; Breimer D D; Cohen A F
Effects of intravenous temazepam. II. A study of the long-term reproducibility of pharmacokinetics, pharmacodynamics, and concentration-effect parameters.
Clinical pharmacology and therapeutics 1994;55(5):546-55.
1994: van Steveninck A L; Schoemaker H C; den Hartigh J; Rijnkels J; Pieters M S; Breimer D D; Cohen A F
Effects of intravenous temazepam. I. Saccadic eye movements and electroencephalogram after fast and slow infusion to pseudo steady state.
Clinical pharmacology and therapeutics 1994;55(5):535-45.
1994: Burggraaf J; Schoemaker H C; Kroon J M; Huisman L; Kluft C; Cohen A F
Influence of 1-desamino-8-D-vasopressin on endogenous fibrinolysis, haemodynamics and liver blood flow in healthy subjects.
Clinical science (London, England : 1979) 1994;86(5):497-503.
1993: Wallnöfer A E; van Griensven J M; Schoemaker H C; Cohen A F; Lambert W; Kluft C; Meijer P; Kooistra T
Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans.
Thrombosis and haemostasis 1993;70(6):1005-8.
1993: Pijl H; Koppeschaar H P; Cohen A F; Iestra J A; Schoemaker H C; Frölich M; Onkenhout W; Meinders A E
Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(9):513-20.
1993: De Boer A; Kluft C; Kasper F J; Kroon J M; Schoemaker H C; Breimer D D; Soons P A; Cohen A F
Interaction study between nifedipine and recombinant tissue-type plasminogen activator in healthy subjects.
British journal of clinical pharmacology 1993;36(2):99-104.
1993: Van Steveninck A L; Mandema J W; Tuk B; Van Dijk J G; Schoemaker H C; Danhof M; Cohen A F
A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity.
British journal of clinical pharmacology 1993;36(2):109-15.
1993: de Boer A; Kluft C; Gerloff J; Dooijewaard G; Günzler W A; Beier H; van der Meer F J; Cohen A F
Pharmacokinetics of saruplase, a recombinant unglycosylated human single-chain urokinase-type plasminogen activator and its effects on fibrinolytic and haemostatic parameters in healthy male subjects.
Thrombosis and haemostasis 1993;70(2):320-5.
1993: Stiekema J C; Van Griensven J M; Van Dinther T G; Cohen A F
A cross-over comparison of the anti-clotting effects of three low molecular weight heparins and glycosaminoglycuronan.
British journal of clinical pharmacology 1993;36(1):51-6.
1993: Van Rooij J; Schoemaker H C; Bruno R; Reinhoudt J F; Breimer D D; Cohen A F
Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastine.
British journal of clinical pharmacology 1993;35(6):661-3.
1993: Wallnöfer A E; Cohen A F
Good clinical practice: a question of balance.
British journal of clinical pharmacology 1993;35(5):449-50.
1993: Cohen A F; Kroon R; Schoemaker H C; Breimer D D; Van Vliet-Verbeek A; Brandenburg H C
The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
British journal of clinical pharmacology 1993;35(2):136-42.
1993: van Steveninck A L; Pieters M S; Schoemaker H C; Breimer D D; Cohen A F
CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
British journal of clinical pharmacology 1993;35(2):114-20.
1993: Mulders T M; Venizelos V; Schoemaker R; Cohen A F; Breimer D D; Mulder G J
Characterization of glutathione conjugation in humans: stereoselectivity in plasma elimination pharmacokinetics and urinary excretion of (R)- and (S)-2-bromoisovalerylurea in healthy volunteers.
Clinical pharmacology and therapeutics 1993;53(1):49-58.
1993: Soons P A; Mulders T M; Uchida E; Schoemaker H C; Cohen A F; Breimer D D
Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.
European journal of clinical pharmacology 1993;44(2):163-9.
1993: Soons P A; Cohen A F; Breimer D D
Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers.
European journal of clinical pharmacology 1993;44(2):113-20.
1993: van Griensven J M; Seibert-Grafe M; Schoemaker H C; Frölich M; Cohen A F
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol.
European journal of clinical pharmacology 1993;45(3):255-60.
1993: van Steveninck A L; Gieschke R; Schoemaker H C; Pieters M S; Kroon J M; Breimer D D; Cohen A F
Pharmacodynamic interactions of diazepam and intravenous alcohol at pseudo steady state.
Psychopharmacology 1993;110(4):471-8.
1992: Cohen A F; Burggraaf K; de Boer A; Kluft C
Clearance of plasminogen activator--a major determinant of plasma concentration: therapeutic and diagnostic implications.
Annals of the New York Academy of Sciences 1992;667():443-9.
1992: Kroon C; ten Hove W R; de Boer A; Kroon J M; van der Pol J M; Harthoorn-Lasthuizen E J; Schoemaker H C; van der Meer F J; Cohen A F
Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.
Circulation 1992;86(5):1370-5.
1992: de Boer A; Kluft C; Dooijewaard G; Kasper F J; Kroon J M; Breimer D D; Stiekema J C; Cohen A F
Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
Thrombosis and haemostasis 1992;68(5):550-5.
1992: van Steveninck A L; Verver S; Schoemaker H C; Pieters M S; Kroon R; Breimer D D; Cohen A F
Effects of temazepam on saccadic eye movements: concentration-effect relationships in individual volunteers.
Clinical pharmacology and therapeutics 1992;52(4):402-8.
1992: Krulder J W; de Boer A; van den Besselaar A M; Cohen A F; Schoemaker H C; Briët E; Meinders A E
Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.
Thrombosis and haemostasis 1992;68(1):30-2.
1992: de Boer A; Kroon J M; Kroon C; van Vliet A; Schoemaker H C; Breimer D D; Donoghue S; Cohen A F
Pronounced effects of the combination of a new thromboxane antagonist (GR32191) and heparin on bleeding time in man.
Thrombosis and haemostasis 1992;68(1):24-9.
1992: Mandema J W; Tuk B; van Steveninck A L; Breimer D D; Cohen A F; Danhof M
Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.
Clinical pharmacology and therapeutics 1992;51(6):715-28.
1992: Soons P A; Schoemaker H C; Cohen A F; Breimer D D
Intraindividual variability in nifedipine pharmacokinetics and effects in healthy subjects.
Journal of clinical pharmacology 1992;32(4):324-31.
1992: de Boer A; Kluft C; Kroon J M; Kasper F J; Schoemaker H C; Pruis J; Breimer D D; Soons P A; Emeis J J; Cohen A F
Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.
Thrombosis and haemostasis 1992;67(1):83-7.
1992: Pieters M S; Jennekens-Schinkel A; Schoemaker H C; Cohen A F
Self-selection for personality variables among healthy volunteers.
British journal of clinical pharmacology 1992;33(1):101-6.
1991: Soons P A; De Boer A; Cohen A F; Breimer D D
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
British journal of clinical pharmacology 1991;32(6):697-704.
1991: Soons P A; Vogels B A; Roosemalen M C; Schoemaker H C; Uchida E; Edgar B; Lundahl J; Cohen A F; Breimer D D
Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans.
Clinical pharmacology and therapeutics 1991;50(4):394-403.
1991: Cohen A F; Kroon R; Schoemaker R; Hoogkamer H; van Vliet A
Influence of gastric acidity on the bioavailability of digoxin.
Annals of internal medicine 1991;115(7):540-5.
1991: de Boer A; Stiekema J C; Danhof M; van Dinther T G; Boeijinga J K; Cohen A F; Breimer D D
Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.
Antimicrobial agents and chemotherapy 1991;35(10):2110-5.
1991: Koster R W; Cohen A F; Kluft C; Kasper F J; van der Wouw P A; Weatherley B C
The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarction.
Clinical pharmacology and therapeutics 1991;50(3):267-77.
1991: van Steveninck A L; Schoemaker H C; Pieters M S; Kroon R; Breimer D D; Cohen A F
A comparison of the sensitivities of adaptive tracking, eye movement analysis and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers.
Clinical pharmacology and therapeutics 1991;50(2):172-80.
1991: de Boer A; Danhof M; Cohen A F; Magnani H N; Breimer D D
Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
Thrombosis and haemostasis 1991;66(2):202-7.
1991: Kroon C; de Boer A; Kroon J M; Schoemaker H C; van den Meer F J; Cohen A F;
Influence of skinfold thickness on heparin absorption.
Lancet 1991;337(8747):945-6.
1991: Dooijewaard G; de Boer A; Turion P N; Cohen A F; Breimer D D; Kluft C
Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma.
Thrombosis and haemostasis 1991;65(1):82-6.
1990: Cohen A F; van Hall M A; van Harten J; Schoemaker R C; Johansson P; Breimer D D; Visser R; Edgar B
The influence of infusion rate on the hemodynamic effects of felodipine.
Clinical pharmacology and therapeutics 1990;48(3):309-17.
1990: Kroon C; de Boer A; Hoogkamer J F; Schoemaker H C; van der Meer E J; Edelbroek P M; Cohen A F
Detection of drug interactions with single dose acenocoumarol: new screening method?
International journal of clinical pharmacology, therapy, and toxicology 1990;28(8):355-60.
1990: van den Berg G; van Steveninck F; Gubbens-Stibbe J M; Schoemaker H C; de Boer A G; Cohen A F
Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.
European journal of clinical pharmacology 1990;39(3):315-6.
1989: Van Hoogdalem E J; Wackwitz A T; De Boer A G; Cohen A F; Breimer D D
Rate-controlled rectal absorption enhancement of cefoxitin by co-administration of sodium salicylate or sodium octanoate in healthy volunteers.
British journal of clinical pharmacology 1989;27(1):75-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Adam Cohen

Research Profile (preview)

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Phenomena

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Adam Cohen (preview)

All Publications